TIDMGSK

RNS Number : 2288M

GlaxoSmithKline PLC

19 January 2021

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms E Walmsley 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Executive Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 14 January 2021. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP14.0488                                                             2,309.116 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-01-18 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Connor 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Vaccines 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 14 January 2021. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP14.0488                                                             1,674.869 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-01-18 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms D Conrad 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Human Resources 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 14 January 2021. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP14.0488                                                             9.025 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-01-18 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr J Ford 
====  ======================================  ================================================= 
 b)    Position/status                        SVP & General Counsel 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 14 January 2021. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP14.0488                                                             0.00003 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-01-18 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr N Hirons 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Ethics & Compliance 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 14 January 2021. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP14.0488                                                             837.932 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-01-18 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms S Jackson 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Communications and CEO Office 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 14 January 2021. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP14.0488                                                             206.502 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-01-18 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                   Mr D Jackson 
====  ======================================  ====================================================== 
 b)    Position/status                        PCA of Ms S Jackson ( SVP, Global Communications 
                                               and CEO Office) 
====  ======================================  ====================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ====================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ====================================================== 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 14 January 2021. 
====  ======================================  ====================================================== 
 c)    Price(s) and                            Price(s)                     Volume(s) 
        volume(s) 
====  ======================================   ===========================  ====================== 
   GBP14.0488                                                               88.201 
   =======================================================================  ====================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ====================================================================  ============================= 
 e)    Date of the transaction                2021-01-18 
====  ======================================  ====================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ====================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr L Miels 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Pharmaceuticals 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 14 January 2021. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP14.0488                                                             2,887.894 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-01-18 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ======================================================================================== 
 a)    Name                                  Mr D Redfern 
====  =====================================  ================================================= 
 b)    Position/status                       Chief Strategy Officer 
====  =====================================  ================================================= 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ======================================================================================== 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ================================================= 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ======================================================================================== 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ================================================= 
 b)    Nature of the                         Acquisition of Ordinary Shares following 
        transaction                           the re-investment of dividends paid to 
                                              shareholders on 14 January 2021. 
====  =====================================  ================================================= 
 c)    Price(s) and                           Price(s)                   Volume(s) 
        volume(s) 
====  =====================================   =========================  =================== 
   GBP 14.0488                                                           3,746.077 
   ====================================================================  =================== 
 
 d)    Aggregated information                N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  ========================== 
 e)    Date of the transaction               2021-01-18 
====  =====================================  ================================================= 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ======================================================================================== 
 a)    Name                                  Mr R Simard 
====  =====================================  ================================================= 
 b)    Position/status                       President, Pharmaceuticals Supply Chain 
====  =====================================  ================================================= 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ======================================================================================== 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ================================================= 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ======================================================================================== 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ================================================= 
 b)    Nature of the                         Acquisition of Ordinary Shares following 
        transaction                           the re-investment of dividends paid to 
                                              shareholders on 14 January 2021. 
====  =====================================  ================================================= 
 c)    Price(s) and                           Price(s)                   Volume(s) 
        volume(s) 
====  =====================================   =========================  =================== 
   GBP 14.0488                                                           738.716 
   ====================================================================  =================== 
 
 d)    Aggregated information                N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  ========================== 
 e)    Date of the transaction               2021-01-18 
====  =====================================  ================================================= 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr P Thomson 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Affairs 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 14 January 2021. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP14.0488                                                             441.416 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-01-18 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ======================================================================================== 
 a)    Name                                  Ms K Thomson 
====  =====================================  ================================================= 
 b)    Position/status                       PCA of Mr P Thomson (President, Global 
                                              Affairs) 
====  =====================================  ================================================= 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ======================================================================================== 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ================================================= 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ======================================================================================== 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ================================================= 
 b)    Nature of the                         Acquisition of Ordinary Shares following 
        transaction                           the re-investment of dividends paid to 
                                              shareholders on 14 January 2021. 
====  =====================================  ================================================= 
 c)    Price(s) and                           Price(s)                   Volume(s) 
        volume(s) 
====  =====================================   =========================  =================== 
   GBP 14.0488                                                           153.299 
   ====================================================================  =================== 
 
 d)    Aggregated information                N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  ========================== 
 e)    Date of the transaction               2021-01-18 
====  =====================================  ================================================= 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ======================================================================================== 
 a)    Name                                  Ms D Waterhouse 
====  =====================================  ================================================= 
 b)    Position/status                       Chief Executive Officer of ViiV Healthcare 
====  =====================================  ================================================= 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ======================================================================================== 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ================================================= 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ======================================================================================== 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ================================================= 
 b)    Nature of the                         Acquisition of Ordinary Shares following 
        transaction                           the re-investment of dividends paid to 
                                              shareholders on 14 January 2021. 
====  =====================================  ================================================= 
 c)    Price(s) and                           Price(s)                   Volume(s) 
        volume(s) 
====  =====================================   =========================  =================== 
   GBP 14.0488                                                           0.014 
   ====================================================================  =================== 
 
 d)    Aggregated information                N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  ========================== 
 e)    Date of the transaction               2021-01-18 
====  =====================================  ================================================= 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHVKLFFFFLBBBB

(END) Dow Jones Newswires

January 19, 2021 13:02 ET (18:02 GMT)

Gsk (LSE:GSK)
過去 株価チャート
から 2 2024 まで 3 2024 Gskのチャートをもっと見るにはこちらをクリック
Gsk (LSE:GSK)
過去 株価チャート
から 3 2023 まで 3 2024 Gskのチャートをもっと見るにはこちらをクリック